Purpose: To summarize current knowledge of the outcome of adenotonsillectomy (T&A) for the treatment of sleep-disordered breathing (SDB) in children. Results: The success rate of T&A for SDB as measured on the basis of objective criteria using polysomnography ranges from 79 to 92%. Dramatic improvements in quality of life after T&A for SDB have been shown in a number of studies and these improvements are maintained up to 2 years after surgery. Significant improvements that are maintained in the long term are also seen in behavioral and neurocognitive parameters following T&A for SDB. Not surprisingly, total health care costs are reduced by one third following T&A mostly because of a reduction in upper respiratory tract infections. Conclusions: T&A is associated with improvements in polysomnography, behavior and quality of life in children with SDB. Improved health in these children leads to a reduction in health care utilization.

Keywords:
Tonsillectomy, Sleep-disordered breathing, Polysomnography, Quality of life
This content is only available via PDF.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.